Adverse drug reactions
Cardiovascular drugs unlikely to worsen erectile dysfunction
A study of more than 2,000 men has shown that antihypertensive and statin use has a neutral effect on erectile dysfunction.
Source: Alain Pol, ISM / Science Photo Library
Researchers say worsening erectile dysfunction should not be a reason for men at risk of cardiovascular disease to discontinue taking antihypertensives and statins
Erectile dysfunction (ED) is associated with cardiovascular disease (CVD) but it is unclear whether medications to treat CVD worsen ED symptoms.
To explore this, researchers analysed data on International Index of Erectile Function (IIEF) erectile function domain scores from a trial in which men with at least one cardiovascular risk factor were randomly assigned to antihypertensive treatment (fixed-dose candesartan 16mg and hydrochlorothiazide 12.5mg) or placebo, and rosuvastatin 10mg or placebo.
Over a mean follow-up of 5.8 years in 2,153 men, the researchers found no significant difference in the mean IIEF score change from baseline with either antihypertensive or statin treatment alone versus placebo, nor between antihypertensive and statin treatment versus double placebo.
Writing in the Canadian Journal of Cardiology (January 2018), the researchers said the findings indicate that antihypertensive and statin use has a neutral effect on symptoms of ED, and worsening ED should not be a reason for men at risk of CVD to discontinue these treatments[1].
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204465
Recommended from Pharmaceutical Press
- Previous
- Next
Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.
£22.00
The only pharmacy-specific OSCE revision guide. This easy-to-use book covers the key competencies that will be tested in your exams.
£25.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.
£48.00
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.
£38.00
The Handbook of Pharmaceutical Excipients contains essential data on the physical properties of excipients, their safe use and potential toxicity.
£415.00
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.